Apidra and Wound - a phase IV clinical study of FDA data

Summary:

Wound is reported as a side effect among people who take Apidra (insulin glulisine recombinant), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Inderal, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Wound when taking Apidra. It is created by eHealthMe based on reports of 10,479 people who have side effects when taking Apidra from the FDA, and is updated regularly.

What is Apidra?

Apidra has active ingredients of insulin glulisine recombinant. It is often used in diabetes. eHealthMe is studying from 10,548 Apidra users. Check the latest studies of Apidra.

What is Wound?

Wound is found to be associated with 1,318 drugs and 1,349 conditions by eHealthMe. Check the latest studies of Wound.

On Jul, 10, 2026

10,479 people reported to have side effects when taking Apidra.
Among them, 23 people (0.22%) have Wound.

Among these 23 people:

How long have people been on Apidra when they have Wound? *

What is the gender of people who have Wound when taking Apidra? *

female: 50 %
male: 50 %

What is the age of people who have Wound when taking Apidra? *

What are other drugs people take besides Apidra? *

What are other side effects people have besides Wound? *

Blood Glucose Increased: 7 people, 30.43%
Hypoglycemia (low blood sugar): 6 people, 26.09%
Fainting (loss of consciousness and postural tone): 5 people, 21.74%
Hyperglycemia (high blood sugar): 4 people, 17.39%
Headache (pain in head): 4 people, 17.39%
Localised Infection (infection at the single location): 4 people, 17.39%
Burning Sensation: 4 people, 17.39%
Pain: 4 people, 17.39%
Drop Attacks (sudden spontaneous falls while standing or walking): 4 people, 17.39%
Fall: 4 people, 17.39%

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 21.74%
Depression: 2 people, 8.70%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.70%
High Blood Cholesterol: 2 people, 8.70%
Urinary Tract Infection: 1 person, 4.35%
Micturition Disorder (disease of passing urine): 1 person, 4.35%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 4.35%
Gastric Disorder (disease of stomach): 1 person, 4.35%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.35%
High Blood Pressure: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Apidra and have Wound?

- Check whether Wound is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apidra:

Apidra (10,548 reports)

Wound treatments and more:

Wound (33,879 reports)

Browse all side effects of Apidra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Wound:

Wound (1,318 drugs)

Browse all the conditions that are associated with Wound:

Wound (1,349 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glulisine recombinant (the active ingredients of Apidra) and Apidra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.